Simultaneous up-dosing of bee and vespid venom immunotherapy is safe.
作者信息
Čerpes Urban, Arzt-Gradwohl Lisa, Schrautzer Christoph, Koch Lukas, Bokanovic Danijela, Laipold Karin, Tripolt Patrik, Binder Barbara, Sturm Gunter J
机构信息
Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Allergy Outpatient Clinic Reumannplatz, Vienna, Austria.
出版信息
Allergy. 2020 Mar;75(3):721-723. doi: 10.1111/all.14079. Epub 2019 Oct 23.
Abstract
摘要
相似文献
1
Simultaneous up-dosing of bee and vespid venom immunotherapy is safe.同时增加蜂毒和黄蜂毒液免疫疗法的剂量是安全的。
Allergy. 2020 Mar;75(3):721-723. doi: 10.1111/all.14079. Epub 2019 Oct 23.
2
Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.蜂类蜇刺复发频率的风险评估：对变应原免疫治疗决策的影响。
Int Arch Allergy Immunol. 2013;160(1):86-92. doi: 10.1159/000338942. Epub 2012 Sep 1.
3
[Wasp and bee venom allergy].[黄蜂和蜜蜂毒液过敏]
Ned Tijdschr Geneeskd. 1998 Apr 18;142(16):889-92.
4
[Bee and wasp venom allergy].[蜜蜂和黄蜂毒液过敏]
Fortschr Med. 1989 Jul 20;107(21):460-3.
5
Safety of hymenoptera venom immunotherapy: a systematic review.蜂类毒液免疫治疗的安全性：系统评价。
Expert Opin Pharmacother. 2011 Nov;12(16):2527-32. doi: 10.1517/14656566.2011.616494. Epub 2011 Sep 2.
6
Good tolerability when switching from an aqueous ultra-rush Hymenoptera venom immunotherapy to a depot preparation.从水性超快速膜翅目毒液免疫疗法转换为长效制剂时耐受性良好。
Allergy. 2020 Jul;75(7):1800-1802. doi: 10.1111/all.14227. Epub 2020 Mar 3.
7
Stinging insect allergy and venom immunotherapy.蜂蜇昆虫过敏与毒液免疫疗法。
Allergy Asthma Proc. 2004 Jul-Aug;25(4 Suppl 1):S9-10.
8
Venom immunotherapy for Hymenoptera allergy in a dog.蜂类过敏的犬类采用毒液免疫疗法。
Vet Dermatol. 2021 Apr;32(2):206-e52. doi: 10.1111/vde.12931. Epub 2021 Jan 13.
9
Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.蜜蜂和黄蜂过敏中的毒液特异性IgG抗体：与免受蜇伤的保护作用缺乏相关性。
Clin Exp Allergy. 1993 Aug;23(8):647-60. doi: 10.1111/j.1365-2222.1993.tb01791.x.
10
[Bee and wasp venom allergy. Clinical aspects, prevention and therapy].[蜜蜂和黄蜂毒液过敏。临床方面、预防与治疗]
MMW Munch Med Wochenschr. 1982 Jun 18;124(24):587-90.
引用本文的文献
1
Cosmetic Applications of Bee Venom.蜂毒的美容应用。
Toxins (Basel). 2021 Nov 18;13(11):810. doi: 10.3390/toxins13110810.
本文引用的文献
1
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy.EAACI 指南：变应原免疫治疗：蜂类毒液过敏。
Allergy. 2018 Apr;73(4):744-764. doi: 10.1111/all.13262. Epub 2017 Dec 5.
2
Safety and efficacy of venom immunotherapy: a real life study.毒液免疫疗法的安全性与有效性：一项实际应用研究。
Postepy Dermatol Alergol. 2017 Apr;34(2):159-167. doi: 10.5114/ada.2017.67082. Epub 2017 Apr 13.
3
Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase.血管紧张素转换酶抑制剂不会损害膜翅目毒液免疫治疗起始阶段的安全性。
Clin Exp Allergy. 2014;44(5):747-55. doi: 10.1111/cea.12276.
4
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.变应原免疫治疗蜂类毒液过敏的诱导期不良反应预测因素：基础血清类胰蛋白酶的重要性。
J Allergy Clin Immunol. 2010 Jul;126(1):105-11.e5. doi: 10.1016/j.jaci.2010.04.025. Epub 2010 Jun 12.
5
The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.以1微克毒液提取物开始进行膜翅目昆虫免疫疗法的安全性。
J Allergy Clin Immunol. 2009 Aug;124(2):379-81. doi: 10.1016/j.jaci.2009.05.026. Epub 2009 Jun 27.
6
Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.拉什膜翅目昆虫毒液免疫疗法：一种针对高危患者的安全实用方案。
J Allergy Clin Immunol. 2002 Dec;110(6):928-33. doi: 10.1067/mai.2002.129124.
7
Incidence and severity of anaphylactoid reactions to colloid volume substitutes.对胶体容量替代物过敏样反应的发生率和严重程度。
Lancet. 1977 Feb 26;1(8009):466-9. doi: 10.1016/s0140-6736(77)91953-5.
Zotero 插件